An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis
N Garg, TW Smith - Brain and behavior, 2015 - Wiley Online Library
Background Multiple sclerosis is an acquired demyelinating disease of the central nervous
system. It is the second most common cause of disability in adults in United States after head …
system. It is the second most common cause of disability in adults in United States after head …
The immunogenetics of multiple sclerosis: A comprehensive review
JA Hollenbach, JR Oksenberg - Journal of autoimmunity, 2015 - Elsevier
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system and
common cause of non-traumatic neurological disability in young adults. The likelihood for an …
common cause of non-traumatic neurological disability in young adults. The likelihood for an …
Effector T cells in multiple sclerosis
BJ Kaskow, C Baecher-Allan - Cold Spring …, 2018 - perspectivesinmedicine.cshlp.org
Multiple sclerosis (MS) has long been considered a CD4 T-cell disease, primarily because
of the findings that the strongest genetic risk for MS is the major histocompatibility complex …
of the findings that the strongest genetic risk for MS is the major histocompatibility complex …
The genetics of multiple sclerosis: from 0 to 200 in 50 years
SE Baranzini, JR Oksenberg - Trends in genetics, 2017 - cell.com
Multiple sclerosis (MS) is a common autoimmune disease that targets myelin in the central
nervous system (CNS). Multiple genome-wide association studies (GWAS) over the past 10 …
nervous system (CNS). Multiple genome-wide association studies (GWAS) over the past 10 …
Neolithic and Bronze Age migration to Ireland and establishment of the insular Atlantic genome
The Neolithic and Bronze Age transitions were profound cultural shifts catalyzed in parts of
Europe by migrations, first of early farmers from the Near East and then Bronze Age herders …
Europe by migrations, first of early farmers from the Near East and then Bronze Age herders …
Immunology of multiple sclerosis
M Sospedra, R Martin - Annu. Rev. Immunol., 2005 - annualreviews.org
▪ Abstract Multiple sclerosis (MS) develops in young adults with a complex predisposing
genetic trait and probably requires an inciting environmental insult such as a viral infection …
genetic trait and probably requires an inciting environmental insult such as a viral infection …
Multiple sclerosis: pathogenesis and treatment
I Loma, R Heyman - Current neuropharmacology, 2011 - ingentaconnect.com
Multiple sclerosis (MS) is a chronic inflammatory autoimmune demyelinating disease of the
central nervous system. It affects approximately 400,000 people in the United States and …
central nervous system. It affects approximately 400,000 people in the United States and …
Multiple sclerosis: risk factors, prodromes, and potential causal pathways
Multiple sclerosis (MS) is a common, complex neurological disease. The precise aetiology of
MS is not yet known, although epidemiological data indicate that both genetic and …
MS is not yet known, although epidemiological data indicate that both genetic and …
The beneficial role of autophagy in multiple sclerosis: yes or no?
Multiple sclerosis (MS) is a chronic progressive demyelinating disease of the central
nervous system (CNS) due to an increase of abnormal peripherally auto-reactive T …
nervous system (CNS) due to an increase of abnormal peripherally auto-reactive T …
[HTML][HTML] The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration
SL Hauser, JR Oksenberg - Neuron, 2006 - cell.com
The autoimmune model of multiple sclerosis (MS) pathogenesis provided for many years a
useful but incomplete conceptual framework for understanding the complex array of factors …
useful but incomplete conceptual framework for understanding the complex array of factors …